Position in GH
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$35,458,090
+$14,007,744 QoQ
Shares Held
236,340
+1.8% QoQ
Ownership
0.176%
of shares outstanding
% of Portfolio
0.44%
of 13F equity value
Holder Rank
#85
of 594 holders
Holding Since
Jun 2025
5 quarters on record
Voting authority
Sole 85%
Shared 0%
None 15%
Common Shares in GH Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026SEGALL BRYANT & HAMILL, LLC holds $116,764,703 across 6 Diagnostics & Research names. GH ranks #2 (30.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VCYT |
Veracyte, Inc.
|
633,227 | $37,189,421 | |
| 2 | GH |
Guardant Health, Inc.
This page
|
236,340 | $35,458,090 | |
| 3 | RDNT |
RadNet, Inc.
|
307,100 | $18,938,857 | |
| 4 | NEO |
Neogenomics Inc
|
1,086,396 | $15,850,517 | |
| 5 | TMO |
Thermo Fisher Scientific Inc.
|
12,973 | $6,504,143 | |
| 6 | DHR |
Danaher Corp /De/
|
14,824 | $2,823,675 |
All Filings in GH
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $35,458,090 | 236,340 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $21,450,346 | 232,222 | Shares | Sole | 2026-05-22 | |
| 2025-12-31 | $24,949,329 | 244,266 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $19,065,584 | 305,147 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $10,060,633 | 193,325 | Shares | Sole | 2025-08-12 | |
| No filing history on record for this holder in this stock. | ||||||